See: https://www.tga.gov.au/advertising-hub and: https://ajp.com.au/news/tga-explains-new-advertising-landscape/
However, there are still concerns about the transparency of the new system and my colleagues and I are holding off submitting complaints until we know:
- The outcome of the TGA Consultation: Complaints handling – Advertising therapeutic goods to the public (and publication of the public submissions).
- The Therapeutic Goods Information (Outcomes of Advertising Complaints Investigations) Specification 2018 has been enacted (which in theory allows for more transparency of compliant outcomes).
Meanwhile, the Therapeutic Goods (Permissible Indications) Determination No.1 of 2018 came into operation on March 6, 2018 while the Choice campaign to disallow it finally produced a commitment from the Labor Party to address consumer concerns if elected. Disallowance was considered impractical as it would have disrupted new listings of complementary medicines. See also: http://medicalrepublic.com.au/alp-commits-disclaimers-evidence-free-medicine/1535.
To-date, there are now around 564 products listed using the new permissible indications determination.
As anticipated, abolishing “free-text” appears to have made little impact given the huge list of industry supplied, TGA endorsed, dubious “permissible” indications. Some examples of the craziness allowed in the ARTG public summaries are:
- Hangover Relief: http://tga-search.clients.funnelback.com/s/search.html?collection=tga-artg&profile=record&meta_i=304293
- Liver Detox Max: http://tga-search.clients.funnelback.com/s/search.html?collection=tga-artg&profile=record&meta_i=304379
- Nature’s Way Slimright Metabolift Fat Burner: http://tga-search.clients.funnelback.com/s/search.html?collection=tga-artg&profile=record&meta_i=304911
- Ashwagandha: http://tga-search.clients.funnelback.com/s/search.html?collection=tga-artg&profile=record&meta_i=304903
- BN caps: http://tga-search.clients.funnelback.com/s/search.html?collection=tga-artg&profile=record&meta_i=303713 (78 permitted indications)!
As anticipated,over 80% of these newly listed products have used the option of invoking “traditional” indications.
by 
